Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cortico-basal degeneration].

E Jankowicz1, W Drozdowski, D Halicka

  • 1Kliniki Neurologii AM w Białymstoku.

Neurologia I Neurochirurgia Polska
|June 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scintillation and radioluminescence mechanism in β-Ga<sub>2</sub>O<sub>3</sub> semiconducting single crystals.

Heliyon·2023
Same author

X-ray Scintillation in Lead Halide Perovskite Crystals.

Scientific reports·2016
Same author

Clinical variability of neuroacanthocytosis syndromes-a series of six patients with long follow-up.

Clinical neurology and neurosurgery·2016
Same author

Tissue invasion and metastasis: Molecular, biological and clinical perspectives.

Seminars in cancer biology·2015
Same author

Metabolite Profile in Pyramidal Tracts after Ischemic Brain Stroke Assessed by 1H MRS. A Multicenter Study.

The neuroradiology journal·2013
Same author

Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.

European journal of neurology·2008

Cortico-basal degeneration (CBD) is a rare neurological disorder causing atrophy in the brain

Area of Science:

  • Neurology
  • Neuroscience
  • Neurodegeneration

Background:

  • Cortico-basal degeneration (CBD) is a neurodegenerative disorder characterized by selective atrophy of the cerebral cortex, primarily parietal and frontal lobes.
  • CBD involves dysfunction of the basal ganglia, leading to prominent extrapyramidal signs like bradykinesia, rigidity, and apraxia, often affecting one body side initially.
  • Neuropathological findings include neuronal loss, gliosis, and achromasia in cortical and subcortical brain regions.

Purpose of the Study:

  • To describe the clinical, neuropathological, and functional characteristics of Cortico-basal degeneration (CBD).
  • To highlight the diagnostic challenges associated with CBD, particularly differentiating it from other neurodegenerative conditions.

Main Methods:

  • Review of clinical symptoms, including extrapyramidal signs and apraxia.

Related Experiment Videos

  • Analysis of neuropathological findings (neuronal loss, gliosis, achromasia).
  • Evaluation of functional imaging studies, such as SPECT, showing hypometabolism.

    • Main Results:

    • CBD presents with asymmetric onset of symptoms, predominantly affecting the left side of the body.
    • Neuropathology reveals characteristic changes in the frontal, parietal cortex, basal ganglia, and substantia nigra.
    • Functional imaging (SPECT) demonstrates corresponding hypometabolic patterns in affected brain areas.

    Conclusions:

    • The etiology and causative treatments for CBD remain unknown.
    • Accurate diagnosis of CBD is challenging and requires prolonged observation to distinguish it from other neurodegenerative diseases like progressive supranuclear palsy, Alzheimer's disease, and Parkinson's disease.